SEGMENT INFORMATION

3 Months Ended

Dec. 31, 2012

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

6. SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K/A for the year ended September 30, 2012.

	Three Months Ended December 31,
	2012			2011
	(Restated)			(Restated)
Revenue:
Service	$	4,670		$	5,611
Product		1,133			1,905
	$	5,803		$	7,516
Operating income (loss):
Service	$	199		$	(1,266	)
Product		103			(36	)
	$	302		$	(1,302	)
Interest Expense		(165	)		(189	)
Change in fair value of warrant liability - (increase) decrease		117			(56	)
Other income		2			-
Income (loss) before income taxes	$	256		$	(1,547	)